Monsenso signs new contract with Psychiatric Centre of Copenhagen
Monsenso signs a new contract with the Psychiatric Centre of Copenhagen. The Monsenso digital health solution will be used to collect real-world data in the precision medicine research project “PRECISE”.
The research project is led by Professor Michael E. Benros, head of research, Biological and Precision Psychiatry at the Copenhagen Research Centre for Mental Health at Copenhagen University Hospital and covers 100 patients with affective disorders.
Precision psychiatry initiative (PRECISE)
The purpose of the “PRECISE” study is to identify biological causes of psychiatric illnesses to identify objective markers for severe psychiatric illnesses by integrating big data from national registries and biobanks into detailed clinical data to improve clinical decision-making and treatment response. Currently, treatment options for mental illness are determined by a “one-size-fits-all” approach, resulting in an unacceptably large proportion of non-responding patients. Collecting and leveraging real-world data may enable more accurate diagnostics, prevention, and new treatment strategies.
Real world-data collection on self-reported and behavioural data
The Monsenso digital health solution will be used to collect data on patient-reported outcomes through clinical questionnaires and daily self-assessments, as well as behavioural data from wearables. In addition, the patients will be offered in-app study information and can receive reminders about medication and consultations with their clinician.
“We are pleased to expand our collaboration with the Psychiatric Centre of Copenhagen and proud to be contributing to the PRECISE project,” says Thomas Lethenborg, CEO of Monsenso. “Mental illness is the biggest disease burden in society in the 2020s. To reduce the burden, it is critical to leverage data to diagnose and monitor mental disorders correctly and to give the right treatment to the right patients. We are happy that the Monsenso solution can contribute to that.
For additional information contact:
Bettina van Wylich-Muxoll
Chief Marketing Officer